From pregnancy to early childhood: innovative solutions for the detection of complications and follow-up

We are looking for disruptive digital solutions specifically in obstetrics and pediatrics that address one of the following areas, always with a clear specialization in maternal and child health and the ability to be integrated into care pathways:

Pregnancy complications: innovative solutions aimed at the early detection and monitoring of relevant obstetric risks and complications, as well as the identification of warning signs.

Illustrative examples: preeclampsia, risk of preterm birth, etc.

Neonates and post-discharge transition: innovative solutions that enable safe early discharge and reduce emergency visits and readmissions by monitoring the newborn at home and enabling early detection of clinical alerts, with a focus on the mother–newborn dyad.

Illustrative examples: at-home neonatal screening (heel prick test, hearing screening, congenital heart disease screening), jaundice, feeding and weight gain, respiratory, digestive or metabolic issues, among others.

Important: These are different sub-challenges; solutions are not required to address both areas.

ELIGIBILITY CRITERIA

Inclusion

• Differentiation and innovation: clearly innovative and differentiated solutions in the market, using disruptive technologies.

• Value proposition: clear impact for both the insurance business and the private hospital environment.

• User: solutions must involve healthcare professionals, regardless of the potential involvement of families.

• Scale of impact: priority will be given to solutions with the potential to impact a relevant population size.

• Focus on early detection, diagnosis and/or monitoring.

• User-friendly and accessible UX: the design and usability of the solution must consider the needs of the target segment, provide an easy-to-use experience, and comply with the European Accessibility Act.

• Ready for adoption: a CIMIT level above 6 will be required.

• Spanish market adaptation plan: if the company is not Spanish, applications must include a plan to adapt the solution to the Spanish population.

• MDR or IVDR compliance, as applicable: solutions must comply with the Medical Device Regulation (MDR) or the In Vitro Diagnostic Medical Device Regulation (IVDR). If not yet compliant, they must have a solid plan to achieve certification within 6 months. Wellbeing solutions will not be considered.

• Legal and regulatory compliance: entities must ensure compliance with all applicable legal and regulatory requirements to operate at European and Spanish levels, including the EU Artificial Intelligence Act, if applicable.

• Entity commitment: entities must ensure the availability of the necessary resources to participate in the different activities of the program.

Exclusion

The following proposals will not be considered:

• ❌ Generic solutions not specialized in obstetrics or pediatrics (e.g., clinical decision support engines not specifically designed for these contexts).

• ❌ Generic educational solutions about pregnancy with no clinical focus on risk detection.

• ❌ Educational solutions focused primarily on breastfeeding.

• ❌ Purely informational apps with no clear clinical criteria or defined care pathways.

• ❌ Therapeutic treatments.

• ❌ Rehabilitation.

• ❌ Oncology.

• ❌ Rare diseases.

• ❌ Pediatric ICU.

Potential collaboration models, if applicable:

·       Proof-of-concept / pilot testing with DKV

·       Client-provider collaboration (commercial agreement)